Variability of the symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome during intermittent therapy with rectal prednisolone foam for ulcerative colitis.
We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2 treatment cycles lends further anecdotal support to our hypothesis that treatment of the immune-mediated response in this chronic condition has a beneficial effect upon symptomatic outcome.
Talbot
M
M
Department of Genito-Urinary Medicine, Royal Hallamshire Hospital, Sheffield S10 2JF, UK. martin.talbot@sth.nhs.uk
Bates
S
S
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017699:Pelvic Pain / Q000150:complications / Q000503:physiopathology*; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011472:Prostatitis / Q000150:complications / Q000503:physiopathology*; D012007:Rectum; D016353:Self-Examination; D013577:Syndrome
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone